Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis.
Development and assessment of a website presenting evidence-based information for people with multiple sclerosis: the IN-DEEP project.
The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects.
The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
Extracellular O-linked β-N-acetylglucosamine: Its biology and relationship to human disease.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
The gut microbiota and its correlations with the central nervous system disorders.
Cognitive rehabilitation correlates with the functional connectivity of the anterior cingulate cortex in patients with multiple sclerosis.
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
Placebo Cohorts in Phase-3 MS Treatment Trials - Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data.
Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.
Neuroprotection in Huntington's disease: a 2-year study on minocycline.
Multiple Sclerosis in Children.
Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy.
Acute hypercalcemia following excessive calcium supplementation in a dehydrated patient with progressive multiple sclerosis: vitamin d supplementation is a red herring-reply.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.
Pages
« first
‹ previous
…
172
173
174
175
176
177
178
179
180
…
next ›
last »